Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weishi Bitong Xifang is a **traditional Chinese medicine (TCM) external herbal preparation** primarily used as a *fumigation and washing therapy* for knee osteoarthritis (KOA)[1][3][4][5]. The formula is composed of a blend of herbal ingredients (such as Semiliquidambar cathayensis, Radix zanthoxyli, Radix aconiti kusnezoffii, Radix aconite, Tinospora sinensis, Erythrina indica, Rheum officinale, and Cassia twig)[2]. Its proposed mechanisms derive from TCM theory—promoting blood circulation, removing stasis, and relieving pain and joint stiffness. Although precise molecular targets are unknown, clinical studies suggest improved pain and function scores and a favorable safety profile compared with standard topical NSAID therapy[1][3][5]. No detailed mechanism of action at the level of modern pharmacology has been demonstrated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weishi Bitong Xifang.